Point-of-care COVID-19 Diagnostic Test Manufacturer: Find the Best Quality Tests for Your Facility

Introducing the latest innovation in COVID-19 testing - the Point-of-care COVID-19 Diagnostic Test. Manufactured by Nanjing Liming Bio-products Co., Ltd., this rapid and reliable test provides accurate results within minutes, allowing for quick decision-making in both clinical and non-clinical settings. Our company, based in China, is a leading supplier and factory of medical diagnostic products, with a strong commitment to quality and innovation. The Point-of-care COVID-19 Diagnostic Test is designed for ease of use, making it ideal for healthcare professionals as well as non-professional users. With its simple procedure and rapid turnaround time, this test enables immediate identification of COVID-19 infection, leading to faster patient care and effective disease control. Whether in hospitals, clinics, or public health centers, this test provides a valuable tool in the fight against the pandemic. Trust Nanjing Liming Bio-products Co., Ltd. to deliver high-quality, reliable diagnostic solutions for COVID-19 testing.
  • Introducing our latest innovation in healthcare technology - the Point-of-care COVID-19 Diagnostic Test. As the world continues to combat the spread of the COVID-19 virus, having fast and accurate testing is crucial to effectively manage and contain the pandemic. Our Point-of-care COVID-19 Diagnostic Test is designed to provide rapid results, allowing for immediate decision making and patient care. This groundbreaking diagnostic test is easy to use and can deliver results within minutes, enabling healthcare professionals to quickly identify and isolate infected individuals. The test is highly sensitive and specific, ensuring reliable results that can aid in monitoring and controlling the spread of the virus. Our Point-of-care COVID-19 Diagnostic Test is suitable for use in a variety of healthcare settings, including hospitals, clinics, and urgent care facilities. Its compact size and user-friendly interface make it an ideal solution for point-of-care testing, allowing for quick and efficient screening of individuals who may be at risk of COVID-19. With the Point-of-care COVID-19 Diagnostic Test, healthcare providers can confidently assess and manage potential cases of COVID-19, helping to protect both patients and staff. We are proud to be at the forefront of providing essential tools for fighting the pandemic, and we are committed to delivering innovative solutions that make a real difference in the battle against COVID-19.
  • Lab Now Accepting COVID-19 Specimens for Testing

    Nanjing Liming Bio-products Co., Ltd. has announced that its rapid test for COVID-19 has shown comparable performance when compared to other methods such as PCR or culture, which are known to be both
  • Rapid antigen detection test for Neisseria gonorrhoeae in urine sediment shows promise in diagnosing gonococcal infection in males

    article based on the study. Researchers have evaluated a rapid antigen detection method with immunochromatographic assay for Neisseria gonorrhoeae in urine sediment to diagnose gonococcal infection i
  • Diagnostic Efficacy of Two Rapid Tests for Detection of Respiratory Syncytial Virus Antigen in Children with Respiratory Symptoms

    Infectious diseases are a major public health concern worldwide, affecting both young and old populations. Respiratory syncytial virus (RSV) is one such infectious disease that is responsible for sign
  • New kit launched to detect and quantify SARS-CoV-2 in wastewater using digital PCR systems

    Nanjing Liming Bio-products Co., Ltd. has announced the development of a new rapid test for detecting sexually transmitted diseases (STDs). The company, which specializes in developing, manufacturing
  • ;